700 results on '"Hughes, Dyfrig"'
Search Results
2. A proposal for using benefit-risk methods to improve the prominence of adverse event results when reporting trials
3. Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
4. Developing an alternative care pathway for emergency ambulance responses for adults with epilepsy: A Discrete Choice Experiment to understand which configuration service users prefer. Part of the COLLABORATE project
5. Service users' preferences and feasibility – which alternative care pathway for adult ambulance users achieves the optimal balance? Workshops for the COLLABORATE project
6. Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
7. The impact of parent treatment preference and other factors on recruitment: lessons learned from a paediatric epilepsy randomised controlled trial
8. Correction: Mechanistically informed non-invasive peripheral nerve stimulation for peripheral neuropathic pain: a randomised double-blind sham-controlled trial
9. Psychometric Properties of an Adapted Stigma Scale and Experiences of Stigma Associated with HIV Pre-exposure Prophylaxis Use Among Men Who have Sex with Men: A Mixed Methods Study
10. Between- and Within-Individual Sociodemographic and Psychological Determinants of PrEP Adherence Among Men Who have Sex with Men Prescribed a Daily PrEP Regimen in Wales
11. Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
12. Spanish translation of the ABC taxonomy for medication adherence
13. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
14. Health utilities and costs for neuromyelitis optica spectrum disorder
15. Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
16. Developing feasible person-centred care alternatives to emergency department responses for adults with epilepsy: a discrete choice analysis mixed-methods study.
17. Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluation
18. Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
19. Acceptability of generic versus innovator oral medicines: not only a matter of taste
20. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics
21. Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study.
22. The experiences and perspectives of people with gout on urate self‐monitoring.
23. A model-based cost-utility analysis of an automated notification system for deteriorating patients on general wards.
24. Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions
25. Utilising benefit-risk assessments within clinical trials—a protocol for the BRAINS project
26. Mechanistically informed non-invasive peripheral nerve stimulation for peripheral neuropathic pain: a randomised double-blind sham-controlled trial
27. Health Utilities and Costs for Motor Neurone Disease
28. The New and Non-Transparent Cancer Drugs Fund
29. Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn’s Disease
30. Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model
31. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease
32. We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.
33. Core Items for a Standardized Resource Use Measure: Expert Delphi Consensus Survey
34. Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods
35. Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital
36. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D
37. A framework for understanding sources of bias in medication adherence research.
38. New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes
39. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial
40. Improving Medication Adherence Research Reporting: European Society for Patient Adherence, Compliance and Persistence Medication Adherence Reporting Guideline
41. CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial
42. Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit--risk assessment: the BRAINS study including expert workshop.
43. Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group
44. Predictors of Self-Reported Adherence to Antihypertensive Medicines: A Multinational, Cross-Sectional Survey
45. Economic Studies in Motor Neurone Disease: A Systematic Methodological Review
46. NICE recommendations : why no disinvestment recommendations to offset investment decisions?
47. Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios
48. Predicting Adherence to Medications Using Health Psychology Theories: A Systematic Review of 20 Years of Empirical Research
49. Impact of non‐adherence on the safety and efficacy of uric acid‐lowering therapies in the treatment of gout
50. PO240 Using routinely recorded data in a clinical trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.